Results 71 to 80 of about 1,251,690 (298)
ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef +2 more
wiley +1 more source
Urologic Cancer Drug Costs in Low- and Middle-Income Countries
All 189 World Bank member countries are classified by their capita gross national income into one of four income groups. In this review, we aim to explore the economic burden and management of urologic oncology conditions in low- and middle-income ...
Lan Anh S. Galloway +2 more
doaj +1 more source
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Background High orphan drug prices have gained the attention of payers and policy makers. These prices may reflect the need to recoup the cost of drug development from a small patient pool.
Kavisha Jayasundara +5 more
doaj +1 more source
Aging Is a Key Driver for Adult Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley +1 more source
OECD Ülkelerinde İlaç Harcamalarının Belirleyicileri
İlaç harcamaları, 1970’ten bu yana GSYİH’nin payı olarak istikrarlı bir şekilde artmaktadır. Bununla birlikte, toplam sağlık harcamaları da artmıştır.
İsmail Biçer
doaj +1 more source
The Courier Conundrum: The High Costs of Prosecuting Low-Level Drug Couriers and What We Can Do About Them [PDF]
Since the United States declared its “War on Drugs,” federal enforcement of drug-trafficking crimes has led to increased incarceration and longer prison sentences.
Weber, Adam B.
core +1 more source
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel +4 more
wiley +1 more source
Study of Drug Utilisation and Adverse Drug Reaction Pattern of Anti-glaucoma Drugs in Patients with Primary Open Angle Glaucoma Attending the Glaucoma Clinic at a Tertiary Care Institute in Bihar, India: A Cross-sectional Study [PDF]
Primary Open Angle Glaucoma (POAG) is a leading cause of secondary blindness, with pharmacotherapy being the mainstay of treatment. As guidelines and recommendations have evolved, so have prescribing trends.
Nitu Pandey +3 more
doaj +1 more source
Does Prescription Drug Adherence Reduce Hospitalizations and Costs? [PDF]
We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from MarketScan® employer data.
Avi Dor, Didem Bernard, William Encinosa
core

